|
⚲
|
| Keyboard |
| Michael Beckloff | |
|---|---|
| Firm | |
| Address | 170 English Landing Drive Suite 201B Parkville, MO 64152 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Bond Biosciences Inc | 021-523360 | Director | 4.5 M of 4.5 M |
||
| Bond Biosciences Inc | 021-427508 | Director | 6.8 M of 10.0 M |
||
| Silvergate Pharmaceuticals Inc | 021-272793 | Executive Officer | 4.6 M of 4.6 M |
||
| Silvergate Pharmaceuticals Inc | 021-249352 | Executive Officer | 1.6 M of 4.6 M |
||
| Silvergate Pharmaceuticals Inc | 021-159955 | Promoter | 23.6 M of 23.6 M |
||